# RISE Adult Medication Study

> **NCT01779362** · PHASE3 · COMPLETED · sponsor: **RISE Study Group** · enrollment: 267 (actual)

## Conditions studied

- Prediabetes
- Type 2 Diabetes

## Interventions

- **DRUG:** Metformin
- **DRUG:** Liraglutide
- **DRUG:** Glargine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01779362
- **Lead sponsor:** RISE Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2019-02
- **Final completion:** 2019-08
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2023-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779362, "RISE Adult Medication Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01779362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*